Ambu A/S (OTCMKTS:AMBBY) Announces Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Trading Down 4.4%

Shares of AMBBY stock traded down $0.60 on Friday, hitting $13.00. The stock had a trading volume of 500 shares, compared to its average volume of 648. The company has a current ratio of 2.77, a quick ratio of 1.69 and a debt-to-equity ratio of 0.08. Ambu A/S has a twelve month low of $8.54 and a twelve month high of $14.18. The company has a fifty day moving average price of $11.10 and a two-hundred day moving average price of $10.99. The firm has a market cap of $3.05 billion, a P/E ratio of 43.33 and a beta of 0.86.

Wall Street Analysts Forecast Growth

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. According to MarketBeat.com, Ambu A/S presently has an average rating of “Hold”.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.